PROFUND ADVISORS LLC

Position in APGE — Apogee Therapeutics, Inc.

CIK 1129919 BETHESDA, MD

Position in APGE

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$2,278,044

-$4,730 QoQ

Shares Held

17,163

-36.7% QoQ

Ownership

0.023%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#150

of 281 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PROFUND ADVISORS LLC holds $162,985,629 across 169 Biotechnology names. APGE ranks #5 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,398	$11,622,488
2	REGN	Regeneron Pharmaceuticals, Inc.	10,444	$6,512,251
3	ALNY	Alnylam Pharmaceuticals, Inc.	13,814	$4,158,428
4	MRNA	Moderna, Inc.	33,142	$2,320,934
5	APGE	Apogee Therapeutics, Inc. This page	17,163	$2,278,044
6	CYTK	Cytokinetics Inc	25,572	$2,178,478
7	KRYS	Krystal Biotech, Inc.	5,770	$2,144,535
8	KYMR	Kymera Therapeutics, Inc.	18,455	$2,116,234

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,278,044	17,163	-36.7%	Shares	Sole	2026-08-11
2026-03-31	$2,282,774	27,121	+48.4%	Shares	Sole	2026-04-27
2025-12-31	$1,379,472	18,276	+29.0%	Shares	Sole	2026-02-06
2025-09-30	$563,013	14,171	+57.8%	Shares	Sole	2025-11-06
2025-06-30	$390,044	8,981	-2.5%	Shares	Sole	2025-08-07
2025-03-31	$344,272	9,215	-19.4%	Shares	Sole	2025-05-08
2024-12-31	$518,050	11,436	+2.9%	Shares	Sole	2025-02-14
2024-09-30	$652,718	11,112	-20.7%	Shares	Sole	2024-11-14
2024-06-30	$551,293	14,010	+28.3%	Shares	Sole	2024-08-13
2024-03-31	$725,634	10,920	—	Shares	Sole	2024-05-08
No filing history on record for this holder in this stock.